1 King William Street

London EC4N 7AF

hello@gbx-events.com

Tel:  0203-858-8185

Fax: 0203-858-8188

  • GBX Events
  • Gbx Events (Summit) You Tube
  • Gbx Events (Summit) Twitter

© 2019 by GBX. Proudly created with GBX Events Ltd.
Company Number: 11782795 - VAT: 317674779 UK

Cell & Gene Therapy Innovation Speaker

Rob Allen

Principal

Rob is a project leader in the biopharmaceutical industry with broad understanding of cell therapies and biologics development. Rob joined Dark Horse Consulting in 2019, bringing over 12 years of experience overseeing clinical trials, regulatory submissions, process improvement, and development strategy. During his career, he has been a part of companies ranging in size and development stage from small entrepreneurial organizations to large corporate pharmaceutical companies. Before joining Dark Horse Consulting, Rob most recently served as Senior Director of Immunotherapy at Asterias Biotherapeutics, a small biopharmaceutical company developing embryonic stem cell-derived therapeutics for spinal injury and cancer. Rob oversaw overall development strategy, cross functional team leadership and clinical trial initiation of the company’s allogeneic cancer immunotherapy platform therapy. He delivered substantial progress of the cancer immunotherapy pipeline asset and a large part of his role was representing the organization to investors and at scientific conferences.